| |
| |
|
| Insider
Information: |
Duggan Robert W |
| Relationship: |
Chief Executive Office... |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
594,894,754 |
|
|
Indirect Shares
|
1,046,059 |
|
|
| Direct
Value |
$5,224,874,671 |
|
|
|
Indirect Value
|
$9,749,033 |
|
|
| Total
Shares |
595,940,813 |
|
|
| Total
Value |
$5,234,623,704 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
19
|
0
|
|
Stock
price went up :
|
17
|
0
|
| Stock
price went down : |
2
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
8.5
|
0.0
|
| Percentage
Gain/Loss : |
 31.8%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Intuitive Surgical Inc |
ISRG |
Director |
2011-05-18 |
1,000 |
2011-02-09 |
0 |
Premium* |
|
|
Pharmacyclics Inc |
PCYC |
Chairman and CEO, Dire... |
2015-05-26 |
0 |
2015-05-26 |
0 |
Premium* |
|
|
Pulse Biosciences, Inc. |
PLSE |
Director, 10% Owner |
2023-12-12 |
36,984,179 |
2023-12-12 |
843,634 |
Premium* |
|
|
Achaogen Inc |
AKAO |
10% Owner |
2019-03-20 |
5,555,414 |
2019-03-20 |
202,425 |
Premium* |
|
|
Summit Therapeutics Inc |
SMMT |
Chief Executive Office... |
2023-03-06 |
552,354,161 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
318 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 11 of 13
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AKAO |
Achaogen Inc |
10% Owner |
– – • |
2018-03-02 |
4 |
B |
$10.14 |
$981,683 |
D/D |
96,790 |
6,205,148 |
2.45 |
- |
|
| ISRG |
Intuitive Surgical Inc |
Director |
– • – |
2006-11-14 |
4 |
S |
$94.70 |
$9,221,173 |
D/D |
(97,000) |
420,541 |
0 |
- |
|
| ISRG |
Intuitive Surgical Inc |
Director |
– • – |
2006-11-15 |
4 |
S |
$94.50 |
$9,235,039 |
D/D |
(97,000) |
323,541 |
0 |
- |
|
| PCYC |
Pharmacyclics Inc |
10% Owner |
– – • |
2006-05-18 |
4 |
B |
$4.00 |
$397,320 |
D/D |
99,330 |
2,168,330 |
2.45 |
- |
|
| PCYC |
Pharmacyclics Inc |
Director |
– • • |
2008-09-05 |
4 |
B |
$2.47 |
$247,000 |
I/I |
100,000 |
515,760 |
2.25 |
- |
|
| AKAO |
Achaogen Inc |
10% Owner |
– – • |
2018-04-27 |
4 |
B |
$12.96 |
$1,333,160 |
D/D |
102,849 |
7,181,002 |
2.45 |
- |
|
| PLSE |
Pulse Biosciences, Inc. |
10% Owner |
– – • |
2017-03-18 |
4 |
B |
$23.01 |
$2,427,127 |
D/D |
105,486 |
2,378,486 |
2.45 |
- |
|
| PLSE |
Pulse Biosciences, Inc. |
10% Owner |
– – • |
2017-04-17 |
4 |
B |
$23.15 |
$2,661,945 |
D/D |
107,300 |
2,686,250 |
2.45 |
- |
|
| PCYC |
Pharmacyclics Inc |
10% Owner |
– – • |
2007-01-03 |
4 |
B |
$4.85 |
$529,276 |
D/D |
108,339 |
3,002,956 |
2.45 |
- |
|
| PLSE |
Pulse Biosciences, Inc. |
Director |
• • • |
2023-12-08 |
4 |
B |
$9.54 |
$1,112,898 |
D/D |
116,656 |
36,876,062 |
3.92 |
% |
|
| ISRG |
Intuitive Surgical Inc |
Director |
– • – |
2005-08-25 |
4 |
S |
$75.94 |
$9,046,448 |
D/D |
(118,000) |
882,884 |
|
- |
|
| AKAO |
Achaogen Inc |
10% Owner |
– – • |
2018-04-19 |
4 |
B |
$12.76 |
$1,527,264 |
D/D |
119,700 |
6,602,269 |
2.45 |
- |
|
| PCYC |
Pharmacyclics Inc |
Director |
– • • |
2008-06-09 |
4 |
A |
$1.64 |
$197,525 |
D/D |
120,442 |
4,694,839 |
0 |
- |
|
| PCYC |
Pharmacyclics Inc |
Director |
– • • |
2008-03-25 |
4 |
D |
$0.00 |
$0 |
I/I |
(121,000) |
415,760 |
0 |
- |
|
| PLSE |
Pulse Biosciences, Inc. |
Director |
• • • |
2023-11-28 |
4 |
B |
$8.98 |
$1,117,085 |
D/D |
124,397 |
36,391,194 |
3.92 |
% |
|
| PCYC |
Pharmacyclics Inc |
Chairman and CEO |
• • • |
2012-12-27 |
5 |
D |
$0.00 |
$0 |
I/I |
(125,000) |
376,119 |
0 |
- |
|
| PCYC |
Pharmacyclics Inc |
Chairman and CEO |
• • • |
2012-12-24 |
5 |
GA |
$0.00 |
$0 |
I/I |
128,628 |
21,438 |
0 |
- |
|
| AKAO |
Achaogen Inc |
10% Owner |
– – • |
2018-05-03 |
4 |
B |
$11.43 |
$1,492,654 |
I/I |
130,255 |
100,255 |
1.5 |
- |
|
| AKAO |
Achaogen Inc |
10% Owner |
– – • |
2018-04-23 |
4 |
B |
$13.07 |
$1,730,969 |
D/D |
132,487 |
6,950,906 |
2.45 |
- |
|
| PCYC |
Pharmacyclics Inc |
Chairman and CEO |
• • • |
2009-07-31 |
4 |
OE |
$1.28 |
$170,691 |
I/I |
133,352 |
649,112 |
0 |
- |
|
| PCYC |
Pharmacyclics Inc |
Chairman and CEO |
• • • |
2012-12-24 |
5 |
GD |
$0.00 |
$0 |
D/D |
150,066 |
13,300,292 |
0 |
- |
|
| PLSE |
Pulse Biosciences, Inc. |
10% Owner |
– – • |
2017-04-19 |
4 |
B |
$22.24 |
$3,567,743 |
D/D |
150,123 |
2,898,192 |
2.45 |
- |
|
| PCYC |
Pharmacyclics Inc |
Chairman and CEO |
• • • |
2015-03-17 |
4 |
GD |
$0.00 |
$0 |
D/D |
152,635 |
13,230,316 |
0 |
- |
|
| PLSE |
Pulse Biosciences, Inc. |
Director |
• • • |
2023-11-30 |
4 |
B |
$9.06 |
$1,385,673 |
I/I |
152,944 |
212,944 |
2.25 |
% |
|
| PLSE |
Pulse Biosciences, Inc. |
10% Owner |
– – • |
2017-08-01 |
4 |
B |
$20.20 |
$3,464,200 |
D/D |
155,486 |
3,265,730 |
2.45 |
- |
|
318 Records found
|
|
Page 11 of 13 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
